Patients with chronic lower-extremity venous ulcers or traumatic ulcers were object of this trial Injury, Occupational Diseases, Poisoning Chronic lower-extremity venous ulcers or traumatic ulcers were object of this trial
Conditions
Interventions
The eiratex® dressing was applied on the wound after surgical debridement, where applicable. The wounds are examined every second day by the attending physician during the first week, and then once pe
Sponsors
Ewecare AB
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Chronic lower limb wounds that were not healed after 6 weeks from the initial injury 2. Treated with eiratex® for the whole treatment 3. Non-infected and infected ulcers 4. Aged from 62 to 85 years old
Exclusion criteria
Exclusion criteria: 1. Patients with exposure of bone, muscle, ligaments, or tendons 2. Patient with mental disorders were excluded to guarantee a conscious agreement to the participation in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Healing time is measured by visual examination from the medical doctor. At each treatment visit, information regarding adverse events, medications and other aspects of care since the last visit was acquired. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Frequency of dressing changes are measured by counting the total number of dressings used during the treatment for each patient, divided by the healing time (in weeks) 2. Number of dressings used are measured by the doctor for each patient. The number of dressings used is related to the number needed to heal the wound | — |
Countries
Sweden
Contacts
Public ContactTobias Sivler
Outcome results
None listed